¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"host versus graft reaction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
¿µ¹® complement fixation reaction ÇÑ±Û º¸Ã¼°áÇÕ ¹ÝÀÀ, µµ¿òü°áÇÕ¹ÝÀÀ
¼³¸í   
  Ç×ü¿ÍÀÇ ¹ÝÀÀ¿¡ À־ º¸Ã¼¿Í °áÇÕÇϴ Ç×ü¸¦ °Ë»çÇϴ ¹æ¹ýÀ¸·Î, ÀÌ ¹ÝÀÀÀº ÃÖÃÊ¿¡ ±âÁöÇ׿ø, ÇǰËÇ÷û ¹× º¸Ã¼¸¦ È¥ÇÕÇÑ´Ù. Á¦2´Ü°è¿¡¼­´Â ÀûÇ÷±¸¿Í À̰Ϳ¡ ´ëÀÀÇϴ ¿ëÇ÷¼ÒÀǠȥÇÕ¾×À» °¡ÇÑ´Ù. º» ¹ÝÀÀÈÄ ¿ëÇ÷ÀÌ ÀϾÁö ¾ÊÀ¸¸é º»Ã¼´Â Ç׿øÇ×ü°áÇÕ¹°¿¡ °áÇÕÇÑ °ÍÀÌ µÇ¾î ¾ç¼ºÀÌ µÇÁö¸¸, ¿ëÇ÷ÀÌ ÀϾ °æ¿ì º¸Ã¼´Â °áÇÕÇÏÁö ¾Ê¾Æ ¼ÒºñµÇÁö ¾Ê±â ¶§¹®¿¡ À½¼ºÀÌ µÈ´Ù. º» ¹ÝÀÀÀº ±âÁöÇ÷ûÀ» ½á¼­ Ç׿ø°ËÃâ¿¡ ÀÀ¿ëÇÒ ¼ö ÀÖÀ¸¸ç, ¸¶ÀÌÄÚÇö󽺸¶, ¸®ÄÉí, Å¬¶ó¹Ìµð¾Æ, ¹ÙÀÌ·¯½º, ¸Åµ¶ µîÀÇ Áø´Ü¿¡ ¾²ÀδÙ.
  
  
¿µ¹® transfusion reaction ÇÑ±Û ¼öÇ÷ºÎÀÛ¿ë, ¼öÇ÷¹ÝÀÀ
¼³¸í   
  ¼öÇ÷ÇÏ¿´À» ¶§¿¡ È¯ÀÚ¿¡°Ô ÀϾ´Â ¹ÝÀÀ. ¾Ë·¹¸£±â ¹ÝÀÀ°ú ¿ëÇ÷ ¹ÝÀÀÀÌ ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • host-controlled modification
    ¼÷ÁÖÁ¶Àý¼ö½Ä
  • host-range mutant
    ¼÷ÁÖ¹üÀ§µ¹¿¬º¯ÀÌÁÖ
  • intermediate host
    Áß°£¼÷ÁÖ
  • primary host
    Á¾¼÷ÁÖ
  • paratenic host
    ¿¬Àå¼÷ÁÖ
  • reservoir host
    º¸À¯¼÷ÁÖ
  • susceptible host
    °¨¼ö¼º¼÷ÁÖ
  • unnatural host
    ºñÈ£Àû¼÷ÁÖ
  • accordion graft
    ¾ÆÄÚµð¾ðÇǺÎÀ̽Ä
  • artificial skin graft
    ÀΰøÇǺÎÀ̽Ä
  • auricular composite graft
    ±Ó¹ÙÄûº¹ÇÕÁ¶Á÷À̽Ä
  • autodermic graft
    ÀÚ°¡ÇǺÎÀ̽Ä
  • autogenous bone graft
    ÀÚ°¡»ÀÀ̽Ä, ÀÚ°¡°ñÀ̽Ä
  • autologous graft
    ÀÚ°¡ÀÌ½ÄÆí
  • alloplastic graft
    ¹«»ý¹°Àç·áÀÌ½ÄÆí
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • reaction fever
    ¹ÝÀÀ¿­
  • reaction
    ¹ÝÀÀ
  • adjustment reaction
    ÀûÀÀ¹ÝÀÀ
  • adverse drug reaction
    ¾à¹°ºÎÀÛ¿ë
  • agglutination reaction
    ÀÀÁý¹ÝÀÀ
  • allergic reaction
    ¾Ë·¹¸£±â¹ÝÀÀ
  • antigen-antibody reaction
    Ç׿øÇ×ü¹ÝÀÀ
  • anxiety reaction
    ºÒ¾È¹ÝÀÀ
  • cascade reaction
    ¿¬¼âÁõÆø¹ÝÀÀ
  • chain reaction
    ¿¬¼â¹ÝÀÀ
  • complement fixation reaction
    µµ¿òü°áÇÕ¹ÝÀÀ, º¸Ã¼°áÇÕ¹ÝÀÀ
  • cross reaction
    ±³Â÷¹ÝÀÀ
  • delayed reaction
    Áö¿¬¹ÝÀÀ
  • inhibition reaction
    ¾ïÁ¦¹ÝÀÀ
  • initial reaction
    Ãʱâ¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • host preference
    ¼÷ÁÖ¼±È£
  • host range
    ¼÷ÁÖ¹üÀ§
  • host selection
    ¼÷ÁÖ¼±ÅÃ
  • host specificity
    ¼÷ÁÖÆ¯À̼º
  • host susceptibility
    ¼÷ÁÖ°¨¼ö¼º
  • host range mutation
    ¼÷ÁÖ¹üÀ§º¯ÀÌ, ¼÷ÁÖ¿ªº¯ÀÌ
  • host-controlled modification
    ¼÷ÁÖÁ¶Àý¼ö½Ä
  • host-parasite relationship
    ¼÷ÁÖ±â»ýü»óÈ£°ü°è
  • host-parasite specificity
    ¼÷ÁÖ±â»ýÃæÆ¯À̼º
  • host-range mutant
    ¼÷ÁÖ¹üÀ§º¯ÀÌÁÖ, ¼÷ÁÖ¿ªµ¹¿¬º¯ÀÌü
  • intermediate host
    Áß°£¼÷ÁÖ
  • natural host
    ÀÚ¿¬¼÷ÁÖ
  • paratenic host
    ¿¬Àå¼÷ÁÖ
  • primary host
    (¢¡definitive host) ÃÖÁ¾¼÷ÁÖ
  • reservoir host
    º¸À¯¼÷ÁÖ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • artificial skin graft
    Àΰø ÇǺÎÀ̽Ä
  • free graft
    À¯¸®À̽Ä(À¯ÀÌÀ̽Ä).
  • free graft
    À¯¸®À̽Ä(ë´ìÆì¹ãÕ).
  • free jejunal graft
    À¯¸®°øÀå À̽ļú
  • full thickness graft
    ÀüÃþÇǺÎÀÌ½ÄÆí(¡­ÇǺÎÀÌ½ÄÆí), ÀüÃþ½ÄÇÇ(¡­½ÄÇÇ).
  • full thickness graft
    ÀüÃþÇǺÎÀÌ½ÄÆí(¡­ù«Ý±ì¹ãÕø¸), ÀüÃþ½ÄÇÇ(¡­ãÕù«).
  • gauntlet graft
    Àå°©»ó À̽İñ Æí(íæË¡ßÒì¹ãÖÍéø¸), ±äÀå°©Çü À̽Ä.
  • graft
    ÀÌ½ÄÆí
  • graft
    À̽Ä(Æí)
  • graft
    Á¶Á÷À̽Ä(ðÚòÄì¹ãÕ)
  • graft =transplantation
    Á¶Á÷À̽Ä(ðÚòÄì¹ ãÕ), ÀÌ½ÄÆí(ì¹ãÕø¸).
  • graft accordion
    ¾ÆÄÚ¿Àµð¾ð½Ä ½ÄÇÇ(¡­½ÄÇÇ).
  • graft accordion
    ¾ÆÄÚ¿Àµð¾ð½Ä ½ÄÇÇ(¡­ãÕù«).
  • graft atherosclerosis
    À̽ÄÁ×»ó°æÈ­Áõ.
  • graft atherosclerosis
    À̽ÄÁ×»ó°æÈ­Áõ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • host controlled variation
    ¼÷ÁÖÀÇÁ¸(±ÔÁ¦)º¯ÀÌ.
  • host defense
    ¼÷ÁÖ¹æ¾î
  • host factor
    ¼÷ÁÖÀÎÀÚ
  • host integration factor (HIF)
    ¼÷ÁÖÅëÇÕÀÎÀÚ
  • host range
    ¼÷ÁÖ¹üÀ§, ¼÷ÁÖ¿ª
  • host range mutation
    ¼÷ÁÖ¿ªº¯ÀÌ
  • host-controlled modification
    ¼÷ÁÖÁ¶Àý¼ö½Ä
  • host-parasite relationship
    ¼÷ÁÖ-±â»ýü »óÈ£°ü°è
  • host-parasite relationship
    ¼÷ÁÖ±â»ýü°ü°è
  • host-parasite relationships
    ¼÷ÁÖ ±â»ýÃæ(»ó°ü) °ü°è
  • host-range mutant
    ¼÷ÁÖ¹üÀ§º¯ÀÌÁÖ
  • intermediate host
    Áß°£¼÷ÁÖ
  • mutant, host range
    ¼÷ÁÖ¿ª µ¹¿¬º¯ÀÌÁÖ
  • pneumonia,in immunocompromised host
    ¸é¿ª±â´ÉÀúÇϼ÷ÁÖÀÇ (Øóæ¹Ñ¦Òöî¸ù»âÖñ«¡­)
  • relation[ship], host-parasite
    ¼÷ÁÖ-±â»ýü »óÈ£°ü°è
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • natural host
    ÀÚ¿¬°¨¿°¼÷ÁÖ
  • principal host
    ÁÖ¼÷ÁÖ
  • reservoir host
    º¸À¯¼÷ÁÖ
  • second intermediate host
    Á¦ÀÌÁß°£¼÷ÁÖ
  • susceptible host
    °¨¼ö¼º¼÷ÁÖ
  • transport host
    ¿î¹Ý¼÷ÁÖ
  • unnatural host
    ºñÈ£Àû¼÷ÁÖ
  • vector host
    ¸Å°³¼÷ÁÖ
  • vicarious host
    ´ë¸®¼÷ÁÖ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Akabori reaction
    ¾ÆÄ«º¸¸®¹ÝÀÀ(Úãëë)
  • alarm reaction
    °æÁ¾¹ÝÀÀ (Ìíñ¤Úãëë)
  • anaphylactoid reaction
    ¾Æ³ªÇʶô½Ã½º¾ç(åÆ) ¹ÝÀÀ(Úãëë)
  • anaplerotic reaction
    º¸Àü¹ÝÀÀ(ÜÍîóÚãëë)
  • annulation reaction
    ȯ»óÇü¼º ¹ÝÀÀ(ü»ßÒû¡à÷Úãëë)
  • anthrone reaction
    ¾ÈÆ®·Ð ¹ÝÀÀ(Úãëë)
  • antigen-antibody reaction
    Ç׿øÇ×ü ¹ÝÀÀ(ù÷ê«ù÷ô÷Úãëë)
  • Arthus reaction
    ¾Æ¸£Åõ½º ¹ÝÀÀ(Úãëë)
  • Berthelot reaction
    º£¸£ÅÐ·Ô ¹ÝÀÀ(Úãëë)
  • Bial's reaction
    ºñ¾Ë ¹ÝÀÀ(Úãëë)
  • bimolecular reaction
    À̺ÐÀÚ ¹ÝÀÀ(ì£ÝÂí­Úãëë)
  • bireactant reaction
    µÎ ¹ÝÀÀ¹°(ÚãëëÚª) ¹ÝÀÀ(Úãëë)
  • bisubstrate reaction
    µÎ ±âÁú(Ðñòõ) ¹ÝÀÀ(Úãëë)
  • biuret reaction
    ºß·¿ ¹ÝÀÀ(Úãëë)
  • capsule swelling reaction
    ĸ½¶ ÆØÃ¢¹ÝÀÀ(ø³óìÚãëë)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • pyrogenic reaction
    ¹ß¿­¹ÝÀÀ
  • reaction
    ¹ÝÀÀ
  • side reaction
    ºÎÀÛ¿ë, ºÎ¹ÝÀÀ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
HVG host versus graft [disease]
LGVHD lethal graft-versus-host disease
SGVHD syngeneic graft-versus-host disease
TAGVHD transfusion-associated graft-versus-host disease
GVL graft versus leukemia
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
GvH Graft versus Host
GVH Graft-versus-host disease
HVG Host versus graft
PT-GVHD Post-transfusion graft-versus-host disease
TA-GVHD Transfusion associated graft versus host disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Blair-Brown graft
    ºí·¹¾î ºê¶ó¿î ÀÌ½ÄÆí
    Áß°£ ÇǺΠµÎ²²ÀÇ ºÐ¿­ ½ÄÇǼú·Î¼­ ÇÇºÎÆí µÎ²²¸¦ Á¤È®È÷ ÃøÁ¤ÇÏ´Â ÀåÄ¡µµ ÀÖ´Ù.
  • bone graft
    °ñ À̽Ä, °ñ ÀÌ½ÄÆí
    1. »ÀÀÇ °á¼Õ º¸ÀüÀ̳ª º¸°­ µîÀ» ¸ñÀûÀ¸·Î °ñÆíÀ» À̽ÄÇÏ´Â ÀÏ. »À°¡ ¿Ü»óÀ̳ª Á¾¾ç¿¡ ÀÇÇÏ¿© ÆÄ±«µÇ¾î °á¼ÕµÈ °æ¿ìÀÇ º¸ÀüÀ̳ª, »ÀÀÇ À̴ܺΰ¡ ¾àÇÏ¿© ±Ù·Â¿¡ °ßµðÁö ¸øÇÒ ¶§ ±× ºÎºÐÀ» À̾ º¸°­Çϰųª, °ñÁúÀÌ ³ªºü °ñ À¯ÇÕÀÌ °ï¶õÇÑ °æ¿ì, »ÀÀÇ Áõ»ýÀ» ÀçÃËÇÏ¿© °ñ À¯ÇÕÀ» ÃËÁøÇÏ·Á ÇÒ ¶§¿¡ ÇàÇÑ´Ù. À̽ÄÇÏ´Â °ñÆíÀº º»ÀÎÀÇ °Í, Áï ÀÚ°¡ °ñÀÌ °¡Àå ÁÁÀ¸¸ç °ñ¹ÝÀÇ Àå°ñ, ´Á°ñ, °æ°ñ µî¿¡¼­ äÃëÇÑ´Ù. ³²ÀÇ »Àµµ ¾²À̸ç, ¶§·Î´Â ¿©·¯ °¡Áö 󸮸¦ ÇÑ µ¿¹°ÀÇ »Àµµ »ç¿ëµÈ´Ù. ÃÖ±Ù ÀϺΠ±¹°¡¿¡¼­´Â ¼ö¼ú ¶§ ÀýÁ¦ÇÑ »À³ª Àý´ÜÁöÀÇ »À, ¶Ç´Â ¿Ü»ó µîÀ¸·Î ±Þ»çÇÑ »ç¶÷ÀÇ »À¸¦ »¡¸® ¹«±ÕÀûÀ¸·Î ²¨³»¾î Àú¿Â º¸Á¸ÇÏ¿´´Ù°¡, ÇÊ¿äÇÒ ¶§ »ç¿ëÇÏ°Ô ÇÏ´Â ¡®»À ÀºÇ࡯µµ ¿î¿µµÇ°í ÀÖ´Ù. 2. °ñÀÌ °á¼ÕµÇ°Å³ª ÀýÁ¦µÈ ºÎÀ§¸¦ ¸Þ¿ì±â À§ÇÏ¿© µ¿¹° ¶Ç´Â ȯÀڷκÎÅÍ ¾òÀº ÀÌ½Ä °ñÆí.
  • brephoplastic graft
    ¹èÅ Á¶Á÷ À̽Ä
    ¹è ¶Ç´Â ½Å»ý¾Æ¿¡¼­ ¼º¼÷ÇÑ µ¿¹°·Î ½ÃÇàÇÏ´Â Á¶Á÷À̽Ä.
  • cancellous graft
    ÇØ¸éÁú°ñ À̽Ä
  • cartilage graft
    ¿¬°ñ À̽Ä
    ¿¬°ñÀ» ü³» ÀÌ½Ä ¶Ç´Â À̽ÄÀ» À§ÇÑ ¿¬°ñ Á¶Á÷.
  • chorioallantoic graft
    À¶¸ð ¿ä¸· À̽Ä
    ´ß žÆÀÇ À¶¸ð ¿ä¸·¿¡ ¼¼Æ÷, Á¶Á÷ ¶Ç´Â ±× ÀϺθ¦ À̽ÄÇÏ´Â °Í.
  • coronary artery bypass graft
    °ü»ó µ¿¸Æ ¿ìȸ À̽ļú, °ü»ó µ¿¸Æ ¿ìȸ·Î¼ú À̽Ä, °ü»ó µ¿¸Æ ¿ìȸ·Î¼ú À̽ļú
  • delayed graft
    Áö¿¬ ÀÌ½ÄÆí
    ÇǺΠÀÌ½ÄÆíÀ» ¶¼ ³½ ±× ÀÚ¸®¿¡ ´Ù½Ã ºÀÇÕÇÑ ´ÙÀ½ »õ·Î¿î ¼ö¿ëó·Î ¿Å±â´Â ÀÌ½ÄÆí.
  • diced cartilage graft
    ÁÖ»çÀ§»ó ¿¬°ñ À̽Ä
    ½ÀÇÑ ¸ð·¡¿Í °°ÀÌ ¿øÇÏ´Â ¸ð¾çÀ¸·Î ¸¸µé ¼ö ÀÖ´Â ´Ù¼öÀÇ ¿¬°ñ ¼ÒÆí. °ñÀ̳ª ¿¬°ñÀÇ °á¼ÕÀ» º¸ÃæÇÏ´Â µ¥ »ç¿ëµÈ´Ù.
  • dural graft
    °æ¸· À̽Ä
  • epidermic graft
    Ç¥ÇÇ À̽Ä, Ç¥ÇÇ ÀÌ½ÄÆí
    ¸Ç»ì¿¡ ÀÌ½ÄµÈ Ç¥ÇÇ Æí.
  • Esser graft
    ¿§¼¼¸£ ÀÌ½Ä Æí
    StentÀÇ ÁÖÇü À§¿¡ ÀÌ½Ä ÇǺθ¦ Æì¼­ ÀÌ½Ä Æí°ú ÁÖÇüÀ» ºÀÇÕÇϰí À̸¦ ¸¸µé¾îÁø Æ÷ÄÏ ¼Ó¿¡ ³Ö´Â ÀÏÁ¾ÀÇ ÀüÃþ ÇǺΠÀÌ½Ä Æí.
  • fascia graft
    ±Ù¸· À̽Ä, ±Ù¸· ÀÌ½ÄÆí
    ´ëÅð ±Ù¸· ¶Ç´Â ¿äÃß ±Ù¸·À¸·ÎºÎÅÍ ¾òÀº ÀÌ½Ä Á¶Á÷.
  • fat graft
    Áö¹æ ÀÌ½ÄÆí, Áö¹æ À̽Ä
    ÁöÁö Á¶Á÷¿¡¼­ ¿ÏÀüÈ÷ À¯¸®½ÃŲ Áö¹æÀÇ À̽Ä. ÇÔ¸ôºÎ¸¦ ¸Þ¿ì±â À§ÇØ »ç¿ëÇÑ´Ù.
  • full thickness graft
    ÀüÃþ ÇǺΠÀÌ½ÄÆí, ÀüÃþ ½ÄÇÇ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
host range The range of host species or cell types which a particular virus, bacteria, or parasite is able to infect or parasitise.
(09 Oct 1997)
host range mutant A mutant of phage or animal virus that grows normally in one of its host cells, but has lost the ability to grow in cells of a second host type.
(18 Nov 1997)
host restriction-modification A bacterial system where the bacterium is able to destroy invading DNA from a bacteriophage (virus which infects bacteria) while at the same time preventing the destruction of their own DNA. The phage DNA is cleaved by a restriction enzyme made by the bacterium, the bacterial DNA is modified (usually with methylation) so that the enzyme will not destroy it.
(09 Oct 1997)
host-vector system A combination of a bacterial host cell (i.e. A specific strain) and a virus vector (i.e. A particular bacteriophage strain) which work well together for DNA cloning.
(09 Oct 1997)
dead-end host A host from which infectious agents are not transmitted to other susceptible host's.
(05 Mar 2000)
definitive host <epidemiology> The host in which a parasite reproduces sexually.
(05 Dec 1998)
immunocompromised host A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation.
(12 Dec 1998)
intermediate host <epidemiology> See vector.
(05 Dec 1998)
transport host An intermediate host in which no development of the parasite occurs, although its presence may be required as an essential link in the completion of the parasite's life cycle; e.g., the successive fish host's that carry the plerocercoid of Diphyllobothrium latum, the broad fish tapeworm, to larger food fish eventually eaten by man or other final host's.
Synonym: transport host.
(05 Mar 2000)
type host <zoology> The host species with which the name-bearing type of a nominal species or subspecies was associated.
(09 Jan 1998)
final host <epidemiology> The host in which a parasite reproduces sexually.
(05 Dec 1998)
accordion graft A skin graft in which multiple slits have been made, so it can be stretched to cover a large area.
Synonym: mesh graft.
(05 Mar 2000)
adipodermal graft A dermal graft with attached subcutaneous fat.
Synonym: adipodermal graft.
(05 Mar 2000)
allogeneic graft <haematology> Grafts between two or more individuals allogeneic at one or more loci (usually with reference to histocompatibility loci). As opposed to autograft and xenograft.
(18 Nov 1997)
anastomosed graft A graft in which circulation is established by surgical anastomoses of blood vessels.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • GVH reaction
    ´ë¼÷ÁÖ ÀÌ½ÄÆí ¹ÝÀÀ(ÀÌ½ÄµÈ Àå±â¿Í ü³» ¸é¿ª ¼¼Æ÷°£ÀÇ ¹ÝÀÀ)
  • atomic reaction
    ¿øÇÙ ¹ÝÀÀ
  • atonic reaction
    ¿øÀÚÇÙ¹ÝÀÀ
  • chain reaction
    ¿¬¼â ¹ÝÀÀ;(»ç°Ç µîÀÇ)¿¬¼â ¹ÝÀÀ
  • dark reaction
    (½Ä)¾Ï¹ÝÀÀ
  • exchange reaction
    (¹°)±³È¯ ¹ÝÀÀ
  • fightorfight reaction
    ¹æÀ§ ¹ÝÀÀÀÇ ÀÏÁ¾
  • fission chain reaction
    Çٺп­ ¿¬¼â ¹ÝÀÀ
  • fusion reaction
    ÇÙÀ¶ÇÕ ¹ÝÀÀ
  • nuclear reaction
    ÇÙ¹ÝÀÀ
  • protective reaction
    ¹æ¾î ¹ÝÀÀ(ÀÚÀ§,º¸º¹À» ¸ñÀûÀ¸·Î ÇÑ Æø°Ý)
  • reaction
    ¹ÝÀÛ¿ë;¹ÝÇ×;¹Ý¹ß;(Á¤Ä¡»óÀÇ)¹Ýµ¿;¿ªÇà;(ÀÚ±Ø.»ç°Ç.¿µÇ⠵ ´ëÇÑ)¹ÝÀÀ;ŵµ;Àǰß;Àλó;(°ú·Î.±äÀå.ÈïºÐ ÈÄÀÇ)Ȱ·Â°¨Åð;¹«±â·Â;¹ÝÀÀ;¹ÝÀÛ¿ë;¹Ýµ¿·Â;ÇÙ¹ÝÀÀ;¹ÝÃæ ÀÛ¿ë;Àç»ý
  • reaction engine
    (·ÎÄÏÀÇ)¿ªÃßÁø ¿£Áø
  • reaction formation
    ¹Ýµ¿ Çü¼º(»çȸÀû.µµ´öÀûÀ¸·Î ÁÁÁö ¾ÊÀº ¿å±¸³ª ¿ø¸ÁÀ» ¾ïÁ¦Çϱâ À§ÇÏ¿© ÀÌ ¿å±¸¿Í´Â ¹Ý´ë ¹æÇâÀÇ µ¶´ÜÀû ÇൿÀ» ÃëÇÏ´Â ¹«ÀǽÄÀû ÇàÀ§)
  • reaction shot
    ¾ó±¼¿¡ ³ªÅ¸³ª´Â ¹ÝÀÀÀ» Àâ´Â ¼ô;Ç¥Á¤ÀÇ Å¬·ÎÁî¾÷
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á